This is a Validated Antibody Database (VAD) review about human FCGR3B, based on 162 published articles (read how Labome selects the articles), using FCGR3B antibody in all methods. It is aimed to help Labome visitors find the most suited FCGR3B antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FCGR3B synonym: CD16; CD16A; CD16b; FCG3; FCGR3; FCGR3A; FCR-10; FCRIII; FCRIIIb

Invitrogen
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:200; loading ...; fig s3a
Invitrogen FCGR3B antibody (Invitrogen, 47-0168-41) was used in flow cytometry on human samples at 1:200 (fig s3a). Nature (2021) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig s3
Invitrogen FCGR3B antibody (Invitrogen, 47-0168-41) was used in flow cytometry on human samples (fig s3). Nature (2021) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:200; fig e4a
Invitrogen FCGR3B antibody (Invitrogen, 47-0168-41) was used in flow cytometry on human samples at 1:200 (fig e4a). Nature (2021) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:25; loading ...
Invitrogen FCGR3B antibody (eBioscience, CB16) was used in flow cytometry on human samples at 1:25. elife (2020) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig 2a
Invitrogen FCGR3B antibody (eBiosciences, CB16) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:50; loading ...; fig 1d
Invitrogen FCGR3B antibody (eBioscience, eBioCB16) was used in flow cytometry on human samples at 1:50 (fig 1d). elife (2020) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig s1a
Invitrogen FCGR3B antibody (eBioscience, 25-0168-42) was used in flow cytometry on human samples (fig s1a). BMC Cancer (2019) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; rhesus macaque; 1:200; loading ...; fig 3g
Invitrogen FCGR3B antibody (Invitrogen, 47-0168-41) was used in flow cytometry on rhesus macaque samples at 1:200 (fig 3g). Nature (2019) ncbi
mouse monoclonal (B73.1)
  • mass cytometry; human; loading ...; fig s1
Invitrogen FCGR3B antibody (eBioscience, B73.1) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:100; loading ...; fig s1a
Invitrogen FCGR3B antibody (Thermofisher, 48-0168-42) was used in flow cytometry on human samples at 1:100 (fig s1a). Cancer Cell (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 1:100; loading ...; fig s1d
Invitrogen FCGR3B antibody (Thermofisher, MHCD1617) was used in flow cytometry on human samples at 1:100 (fig s1d). Cancer Cell (2019) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig s1b, s1c, s1d
Invitrogen FCGR3B antibody (eBioscience, eBioCB16) was used in flow cytometry on human samples (fig s1b, s1c, s1d). Cell Host Microbe (2019) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig 3g
Invitrogen FCGR3B antibody (eBioscience, 46-0168-42) was used in flow cytometry on human samples (fig 3g). Science (2019) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig 9e
Invitrogen FCGR3B antibody (eBiosciences, eBioCB16) was used in flow cytometry on human samples (fig 9e). J Clin Invest (2018) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen FCGR3B antibody (Life Technologies, MHCD1617) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:100; fig 1a
In order to study the interactions among different monocyte populations and vascular endothelial cells, Invitrogen FCGR3B antibody (eBiosciences, eBioCB16) was used in flow cytometry on human samples at 1:100 (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (MEM-154)
  • western blot; human
In order to show that IL-3 is a potent inducer of CD32- and alphaMbeta2-mediated eosinophil degranulation, Invitrogen FCGR3B antibody (Invitrogen, MEM-154) was used in western blot on human samples . Clin Exp Allergy (2017) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:5; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, Invitrogen FCGR3B antibody (eBioscience, CB16) was used in flow cytometry on human samples at 1:5. Nat Commun (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; tbl 1
In order to characterize the role of T-cell depletion and macrophage polarization and infection during splenic damage during SIV infection, Invitrogen FCGR3B antibody (eBioScience, 3G8) was used in flow cytometry on rhesus macaque samples (tbl 1). Am J Pathol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1
In order to report the exercise-induced changes on the blood cell composition of patients with metabolic syndrome, Invitrogen FCGR3B antibody (Caltag, MHCD1605) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; fig 2
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen FCGR3B antibody (eBioscience, CB16) was used in flow cytometry on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; 1:20; loading ...; fig s5j
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen FCGR3B antibody (eBioscience, 48-0168-41) was used in flow cytometry on human samples at 1:20 (fig s5j). Nat Cell Biol (2016) ncbi
mouse monoclonal (3G8)
In order to discuss methods to overcomes the limitations of glutathione S-transferase fusion proteins to study protein-protein interactions, Invitrogen FCGR3B antibody (Life Technologies, MHCD1601) was used . Anal Biochem (2016) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig 1a
In order to examine the expression of CD300 molecules on natural killer cells, Invitrogen FCGR3B antibody (eBiosciences, eBioCB16) was used in flow cytometry on human samples (fig 1a). Sci Rep (2016) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human; 1:200; fig 5
Invitrogen FCGR3B antibody (ebioscience, B73.1) was used in flow cytometry on human samples at 1:200 (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; tbl 2
In order to correlate neutrophil functions with habitual physical activity, Invitrogen FCGR3B antibody (eBiosciences, CB16) was used in flow cytometry on human samples (tbl 2). Brain Behav Immun (2016) ncbi
mouse monoclonal (MEM-154)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the influence of peripheral blood monocytes on human cardiac myofibroblast activity, Invitrogen FCGR3B antibody (Thermo Scientific, MEM-154) was used in flow cytometry on human samples (fig 1a). Am J Physiol Heart Circ Physiol (2016) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; fig 1
Invitrogen FCGR3B antibody (eBioscience, 11-0168) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Invitrogen FCGR3B antibody (Invitrogen, 3G8) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; fig 3
Invitrogen FCGR3B antibody (eBioscience, 48-0168-42) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2015) ncbi
mouse monoclonal (3G8)
  • immunoprecipitation; human
Invitrogen FCGR3B antibody (eBioscience, 3G8) was used in immunoprecipitation on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; fig 1
Invitrogen FCGR3B antibody (eBioscience, CB16) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human
Invitrogen FCGR3B antibody (eBioscience, CB16) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to examine various DC after flu vaccination, Invitrogen FCGR3B antibody (Invitrogen, 3G8) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human
Invitrogen FCGR3B antibody (eBiosciences, eBioCB16) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (MEM-154)
  • flow cytometry; human
In order to determine how NK cells are recruited for lysis of CD30+ tumor cells by a novel tetravalent bispecific TandAb (CD30/CD16A), Invitrogen FCGR3B antibody (Fisher, MA1?C19563) was used in flow cytometry on human samples . MAbs (2014) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human; loading ...; fig 1
In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, Invitrogen FCGR3B antibody (eBioscience, CB16) was used in flow cytometry on human samples (fig 1). Exp Gerontol (2014) ncbi
mouse monoclonal (eBioCB16 (CB16))
  • flow cytometry; human
Invitrogen FCGR3B antibody (eBioscience, 17-0168) was used in flow cytometry on human samples . Arthritis Res Ther (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; loading ...; fig 3
In order to develop a newborn/infant model to study infection with Mycobacterium tuberculosis, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on rhesus macaque samples (fig 3). Tuberculosis (Edinb) (2013) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 8
In order to explore the role of HIV in potentially modulating macrophage function, Invitrogen FCGR3B antibody (eBioscience, 3G8) was used in flow cytometry on human samples (fig 8). Retrovirology (2013) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
In order to discuss methods to detect fetomaternal hemorrhage, Invitrogen FCGR3B antibody (Caltag-Medsystems, Clone 3G8) was used in flow cytometry on human samples (fig 1). Transfusion (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, Invitrogen FCGR3B antibody (Caltag, clone 3G8) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 3
In order to study the immediate innate immune response after an ischemic insult, Invitrogen FCGR3B antibody (CalTag, MHCD1605) was used in flow cytometry on human samples (fig 3). J Neuroinflammation (2013) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen FCGR3B antibody (CALTAG, MHCD1601) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human; fig s6
Invitrogen FCGR3B antibody (eBioscience, B73.1) was used in flow cytometry on human samples (fig s6). PLoS Pathog (2012) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
In order to characterize therapy-induced T cell reactivity using a panel of 145 melanoma-associated CD8(+) T cell epitopes, Invitrogen FCGR3B antibody (Invitrogen, MHCD1629) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2012) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to study heme oxygenase-1 in HIV-infected people, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Genes Immun (2012) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
mouse monoclonal (3G8)
  • flow cytometry; mouse
In order to determine the origin of tumor macrophages, Invitrogen FCGR3B antibody (Invitrogen, 3G8) was used in flow cytometry on mouse samples . Nature (2011) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1, 2, 3
In order to test if Th1- and Th2-like conditions alter antigen expression and function of plasmacytoid dendritic cells, Invitrogen FCGR3B antibody (Invitrogen, 3G8) was used in flow cytometry on human samples (fig 1, 2, 3). Allergy (2011) ncbi
mouse monoclonal (3G8)
  • flow cytometry; African green monkey; fig 4
In order to characterize natural killer T subsets in sooty mangabey, Invitrogen FCGR3B antibody (Invitrogen, 3G8) was used in flow cytometry on African green monkey samples (fig 4). J Med Primatol (2010) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to study the effect of natural occurring viral ssRNA on DC function, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . J Immunol (2009) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 3
In order to test if activation of monocytes via FcgammaR induced cell differentiation, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 3). J Immunol (2009) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque
In order to discuss the effects of in vivo CTLA-4 blockade as a part of a DNA vaccination regimen in cynomolgus macaques, Invitrogen FCGR3B antibody (Invitrogen, 3G8) was used in flow cytometry on rhesus macaque samples . J Med Primatol (2008) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to develop a 6-color assay to identify dendritic cells, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2008) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
In order to assess the immunological status after Bz-treatment during early indeterminate Chagas disease, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 1). Microbes Infect (2008) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 4
In order to test if leukocyte Ig-like receptor A2 regulates DC differentiation using a leprosy model, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 4). J Immunol (2007) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to characterize dendritic cells in type 1 and type 2 diabetes, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Clin Immunol (2006) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to examine the consequences of CD83 ligand engagement on antigen-specific CD8+ T cells, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Blood (2006) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to develop an assay to quantitate the number of latently infected cells carrying replication competent HIV-1, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Methods Mol Biol (2005) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to show that human rhinoviruses alters the accessory molecule repertoire of dendritic cells, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . J Immunol (2005) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to discuss methods to distinguish natural killer cells from natural killer T cells, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Cytometry A (2005) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen FCGR3B antibody (Caltag Laboratories, 3G8) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to elucidate how the monoclonal antibody, 11C9, reduces dendritic cell-induced T cell activation, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . J Immunol (2004) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 2C
  • immunohistochemistry; human; fig 2C
In order to assess the expression of NK cell receptors and cytokines in the human endometrium, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 2C) and in immunohistochemistry on human samples (fig 2C). J Leukoc Biol (2004) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
In order to characterize B7-H3, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 1). J Immunol (2004) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to test if human fetal liver cells expressing CD34 and CK7/8 represent a common stem cell for both the hematopoietic and hepatic systems, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . J Hepatol (2004) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to examine adhesion molecules in patients with restenosis, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (3G8)
  • ELISA; human; fig 6
In order to identify immunoregulatory molecules on dendritic cells, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in ELISA on human samples (fig 6). J Immunol (2003) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to examine CD56 expression in a cohort of acute myeloid leukemia patients in to assess its frequency and prognostic relevance, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Haematologica (2002) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 2 ug/ml
In order to characterize human splenic dendritic cells, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples at 2 ug/ml. Blood (2001) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 2
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples (fig 2). Blood (2000) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen FCGR3B antibody (Caltag, 3G8) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
  • immunoprecipitation; human; fig 2
In order to compare Fc gamma RIII(CD16) transcripts isolated from PMN and NK cells, Invitrogen FCGR3B antibody (invitrogen, 3G8) was used in flow cytometry on human samples (fig 1) and in immunoprecipitation on human samples (fig 2). J Exp Med (1989) ncbi
mouse monoclonal (3G8)
  • immunoprecipitation; human; fig 4
In order to identify a locus for at least two Fc gamma R genes on human chromosome 1, Invitrogen FCGR3B antibody (invitrogen, 3G8) was used in immunoprecipitation on human samples (fig 4). Proc Natl Acad Sci U S A (1989) ncbi
BioLegend
mouse monoclonal (3G8)
  • blocking or activating experiments; human; 5 ug/ml; loading ...; fig s4
BioLegend FCGR3B antibody (Biolegend, 3G8) was used in blocking or activating experiments on human samples at 5 ug/ml (fig s4). BMC Biol (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
BioLegend FCGR3B antibody (Biolegend, 302035) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 7
BioLegend FCGR3B antibody (Biolegend, 302019) was used in flow cytometry on human samples (fig 7). PLoS Negl Trop Dis (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 1:200; loading ...; fig s1a
BioLegend FCGR3B antibody (Biolegend, 302029) was used in flow cytometry on human samples at 1:200 (fig s1a). Arthritis Res Ther (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
BioLegend FCGR3B antibody (BioLegend, 302044) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
BioLegend FCGR3B antibody (Biolegend, 302008) was used in flow cytometry on human samples . BMC Biol (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s9d
BioLegend FCGR3B antibody (BioLegend, 302040) was used in flow cytometry on human samples (fig s9d). Nature (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s3a
BioLegend FCGR3B antibody (Biolegend, 302057) was used in flow cytometry on human samples (fig s3a). Cell Rep (2020) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 3c
BioLegend FCGR3B antibody (Biolegend, 302042) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 4b
BioLegend FCGR3B antibody (Biolegend, clone 3G8) was used in flow cytometry on human samples (fig 4b). Sci Rep (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s1a
BioLegend FCGR3B antibody (BioLegend, 302051) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human; loading ...; fig s2o
BioLegend FCGR3B antibody (Biolegend, 360716) was used in flow cytometry on human samples (fig s2o). JCI Insight (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 6
BioLegend FCGR3B antibody (BioLegend, 302011) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (3G8)
  • other; human; loading ...; fig 4b
BioLegend FCGR3B antibody (BioLegend, 302061) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 3a
BioLegend FCGR3B antibody (BioLegend, 302039) was used in flow cytometry on human samples (fig 3a). J Exp Med (2019) ncbi
mouse monoclonal (3G8)
  • mass cytometry; human; loading ...; fig 2j
BioLegend FCGR3B antibody (Biolegend, 302002) was used in mass cytometry on human samples (fig 2j). Cell (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 6b
BioLegend FCGR3B antibody (BioLegend, 302044) was used in flow cytometry on human samples (fig 6b). Immunity (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s5a
BioLegend FCGR3B antibody (Biolegend, 302012) was used in flow cytometry on human samples (fig s5a). Breast Cancer Res Treat (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FCGR3B antibody (Biolegend, 302035) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1c
BioLegend FCGR3B antibody (BioLegend, 302025) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1a
BioLegend FCGR3B antibody (Biolegend, 302002) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s2d
BioLegend FCGR3B antibody (BioLegend, 302016) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human; loading ...; fig s1a
In order to study the effect off HIV 1 vaccination in HIV carriers, BioLegend FCGR3B antibody (Biolegend, B73.1) was used in flow cytometry on human samples (fig s1a). Front Immunol (2017) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend FCGR3B antibody (BioLegend, 302040) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend FCGR3B antibody (Biolegend, 302012) was used in flow cytometry on human samples (fig 1a). Front Immunol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, BioLegend FCGR3B antibody (Biolegend, 302008) was used in flow cytometry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (3G8)
BioLegend FCGR3B antibody (BioLegend, 302006) was used . Nat Commun (2016) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human; loading ...; fig s1d
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BioLegend FCGR3B antibody (BioLegend, B73.1) was used in flow cytometry on human samples (fig s1d). Sci Rep (2016) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human; 1:100; fig 1a
In order to investigate the impact of a cancer-specific MUC1 glycoform, BioLegend FCGR3B antibody (Biolegend, B73.1) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Immunol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (B73.1)
  • flow cytometry; human
BioLegend FCGR3B antibody (Biolegend, B73.1) was used in flow cytometry on human samples . elife (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 1:100; fig 5
BioLegend FCGR3B antibody (Biolegend, 302007) was used in flow cytometry on human samples at 1:100 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; mouse; 1:200
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 5
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 7
BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (Biolegend, 302008) was used in flow cytometry on human samples . J Neuroimmunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; mouse
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on mouse samples . J Virol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
In order to identify the response to anti-MPO antibodies in the form of increased surface expression of ANCA autoantigens and IL-1beta secretion acting as intermediate monocytes in ANCA vasculitis, BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (BioLegend, 302026) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; fig 3
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 4
BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig 4). J Rheumatol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 7
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig 7). J Immunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples . Genes Immun (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to evaluate immune responses by monocyte isolated from young and old adults before and after influenza vaccination, BioLegend FCGR3B antibody (BioLegend, clone3G8) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque
  • immunohistochemistry; rhesus macaque
In order to examine the diagnostic value of mannose receptor CD206 in HIV and simian immunodeficiency virus encephalitis, BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on rhesus macaque samples and in immunohistochemistry on rhesus macaque samples . J Neuroimmune Pharmacol (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples . Cell Immunol (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend FCGR3B antibody (Biolegend, 3G8) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (3G8)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...
BioLegend FCGR3B antibody (BioLegend, 302005) was used in immunohistochemistry - frozen section on rhesus macaque samples . Mol Ther (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3B antibody (BioLegend, 3G8) was used in flow cytometry on human samples . Clin Cancer Res (2013) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to describe protocols for immunostaining and multiparameter flow cytometric analysis of major human antigen-presenting cells in peripheral blood, BioLegend FCGR3B antibody (BioLegend, 302021) was used in flow cytometry on human samples . Nat Protoc (2010) ncbi
Santa Cruz Biotechnology
rat monoclonal (YFC 120.5)
  • immunohistochemistry; rat; 1:50; loading ...; fig 5a
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz Biotechnology, sc-58962) was used in immunohistochemistry on rat samples at 1:50 (fig 5a). J Neuroinflammation (2021) ncbi
mouse monoclonal (DJ130c)
  • immunohistochemistry - paraffin section; rhesus macaque; 1.3 ug/ml; loading ...; fig s8b
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-20052) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1.3 ug/ml (fig s8b). Science (2020) ncbi
mouse monoclonal (LNK16)
  • flow cytometry; human; 1:20; loading ...; fig 1a
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-51524) was used in flow cytometry on human samples at 1:20 (fig 1a). Sci Adv (2019) ncbi
mouse monoclonal (GRM1)
  • flow cytometry; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology FCGR3B antibody (Santa, GRM1) was used in flow cytometry on human samples (fig 4a) and in western blot on human samples (fig 4b). Blood (2019) ncbi
mouse monoclonal
  • flow cytometry; human; fig 5a
  • western blot; human; fig 5c
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, DJ130c) was used in flow cytometry on human samples (fig 5a) and in western blot on human samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DJ130c)
  • flow cytometry; human; fig 5a
  • western blot; human; fig 5c
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, DJ130c) was used in flow cytometry on human samples (fig 5a) and in western blot on human samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DJ130c)
  • immunohistochemistry; human; 1:400; fig 1h
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-20052) was used in immunohistochemistry on human samples at 1:400 (fig 1h). Front Immunol (2017) ncbi
mouse monoclonal (DJ130c)
  • ELISA; human; loading ...; fig 7d
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-20052) was used in ELISA on human samples (fig 7d). J Cell Mol Med (2017) ncbi
mouse monoclonal (DJ130c)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 1
In order to study P2Y12 expression in human brain tissue, Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-20052) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Glia (2017) ncbi
mouse monoclonal (3G8)
  • immunocytochemistry; human; loading ...; fig 3
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-19620) was used in immunocytochemistry on human samples (fig 3). J Immunol Methods (2016) ncbi
mouse monoclonal (DJ130c)
  • immunohistochemistry - paraffin section; human; 1:100; fig s3
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-20052) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s3). Oncotarget (2016) ncbi
mouse monoclonal (3G8)
  • blocking or activating experiments; human; 1 ug/ml; fig 3
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz Biotechnology, sc-19620) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 3). J Biol Chem (2016) ncbi
mouse monoclonal (3G8)
  • other; mouse; fig 1
  • immunocytochemistry; mouse; fig 2
  • western blot; mouse; fig s1
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz Biotechnology, sc-19620) was used in other on mouse samples (fig 1), in immunocytochemistry on mouse samples (fig 2) and in western blot on mouse samples (fig s1). Mol Biol Cell (2016) ncbi
mouse monoclonal (DJ130c)
  • immunohistochemistry; human
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, sc-20052) was used in immunohistochemistry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (DJ130c)
  • western blot; human; fig 1
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, Sc20052) was used in western blot on human samples (fig 1). J Matern Fetal Neonatal Med (2016) ncbi
mouse monoclonal (2Q1240)
  • immunohistochemistry - paraffin section; human; fig 6
Santa Cruz Biotechnology FCGR3B antibody (Santa Cruz, 2Q1240) was used in immunohistochemistry - paraffin section on human samples (fig 6). Oncol Rep (2015) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 8a
Abcam FCGR3B antibody (Abcam, ab203883) was used in western blot on rat samples (fig 8a). J Inflamm Res (2021) ncbi
domestic rabbit monoclonal (EPR22409-124)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 2h
Abcam FCGR3B antibody (Abcam, ab252908) was used in immunohistochemistry on mouse samples at 1:200 (fig 2h). Aging (Albany NY) (2021) ncbi
mouse monoclonal (MEM-154)
  • immunocytochemistry; human; loading ...; fig 2j
  • western blot; human; loading ...; fig 4f
Abcam FCGR3B antibody (Abcam, ab46679) was used in immunocytochemistry on human samples (fig 2j) and in western blot on human samples (fig 4f). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...; fig 7a
Abcam FCGR3B antibody (Abcam, ab203883) was used in immunohistochemistry on mouse samples at 1:500 (fig 7a). J Comp Neurol (2020) ncbi
Miltenyi Biotec
human monoclonal (REA423)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec FCGR3B antibody (Miltenyi, 130-113-393) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
human monoclonal (REA423)
  • flow cytometry; human; loading ...; fig s2
Miltenyi Biotec FCGR3B antibody (Miltenyi Biotech, 130-113-389) was used in flow cytometry on human samples (fig s2). J Biol Chem (2019) ncbi
Bio-Rad
mouse monoclonal (LNK16)
  • flow cytometry; human; loading ...; fig 1b
Bio-Rad FCGR3B antibody (Immunotools, LNK16) was used in flow cytometry on human samples (fig 1b). Cell Death Dis (2018) ncbi
mouse monoclonal (DJ130c)
  • blocking or activating experiments; human; loading ...; fig 3a
In order to determine the contribution of CD16 positive monocytes to antibody-dependent cellular cytotoxicity, Bio-Rad FCGR3B antibody (AbD Serotec, DJ130c) was used in blocking or activating experiments on human samples (fig 3a). Sci Rep (2016) ncbi
rat monoclonal (YFC120.5)
  • flow cytometry; human; loading ...; fig 4b
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, Bio-Rad FCGR3B antibody (Bio Rad Laboratories, MCA617G) was used in flow cytometry on human samples (fig 4b). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (LNK16)
  • flow cytometry; hamsters
Bio-Rad FCGR3B antibody (AbD Serotec, LNK16) was used in flow cytometry on hamsters samples . PLoS ONE (2014) ncbi
mouse monoclonal (KD1)
  • flow cytometry; bovine; loading ...; fig 4b
Bio-Rad FCGR3B antibody (Serotec, MCA5665) was used in flow cytometry on bovine samples (fig 4b). Theriogenology (2014) ncbi
BD Biosciences
mouse monoclonal (CLB-gran11.5)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences FCGR3B antibody (BD Biosciences, CLB-gran11.5) was used in flow cytometry on human samples (fig s1). Arthritis Res Ther (2021) ncbi
mouse monoclonal (CLB-gran11.5)
  • flow cytometry; human; loading ...; fig 2a
In order to propose that female sex protects against systemic inflammation-induced endothelial dysfunction, BD Biosciences FCGR3B antibody (BD Bioscience, 550868) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2017) ncbi
mouse monoclonal (CLB-gran11.5)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences FCGR3B antibody (BD, 550868) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
Articles Reviewed
  1. Zhu Y, Xie J, Shi J. Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis. BMC Biol. 2021;19:140 pubmed publisher
  2. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  3. Xiao J, Cai T, Fang Y, Liu R, Flores J, Wang W, et al. Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model. J Neuroinflammation. 2021;18:160 pubmed publisher
  4. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed publisher
  5. Jiang T, Xu S, Shen Y, Xu Y, Li Y. Genistein Attenuates Isoflurane-Induced Neuroinflammation by Inhibiting TLR4-Mediated Microglial-Polarization in vivo and in vitro. J Inflamm Res. 2021;14:2587-2600 pubmed publisher
  6. Wang Z, Muecksch F, Schaefer Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426-431 pubmed publisher
  7. Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Spencer Clinton J, Rico Hesse R. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis. 2021;15:e0009427 pubmed publisher
  8. Ukadike K, Ni K, Wang X, Taylor M, LaCava J, Pachman L, et al. IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus. Arthritis Res Ther. 2021;23:153 pubmed publisher
  9. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed publisher
  10. Matsumoto K, Kurasawa T, Yoshimoto K, Suzuki K, Takeuchi T. Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses. Arthritis Res Ther. 2021;23:136 pubmed publisher
  11. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  12. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622 pubmed publisher
  13. Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591:124-130 pubmed publisher
  14. Zhang Z, Zou X, Zhang R, Xie Y, Feng Z, Li F, et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke. Aging (Albany NY). 2021;13:3060-3079 pubmed publisher
  15. Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639-644 pubmed publisher
  16. Wu S, Xu R, Zhu X, He H, Zhang J, Zeng Q, et al. The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization. Aging (Albany NY). 2020;12:25845-25864 pubmed publisher
  17. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed publisher
  18. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  19. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  20. Thulin N, Brewer R, Sherwood R, Bournazos S, Edwards K, Ramadoss N, et al. Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants. Cell Rep. 2020;31:107642 pubmed publisher
  21. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  22. Libner C, Salapa H, Hutchinson C, Lee S, Levin M. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis. J Comp Neurol. 2020;528:1704-1724 pubmed publisher
  23. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  24. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  25. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  26. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  27. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  28. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  29. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  30. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  31. Ling C, Nishimoto K, Rolfs Z, Smith L, Frey B, Welham N. Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Sci Adv. 2019;5:eaav7384 pubmed publisher
  32. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  33. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  34. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  35. Bottermann M, Foss S, Caddy S, Clift D, van Tienen L, Vaysburd M, et al. Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host Microbe. 2019;25:617-629.e7 pubmed publisher
  36. Janela B, Patel A, Lau M, Goh C, Msallam R, Kong W, et al. A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils. Immunity. 2019;50:1069-1083.e8 pubmed publisher
  37. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  38. Sachdeva M, Duchateau P, Depil S, Poirot L, Valton J. Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators. J Biol Chem. 2019;294:5430-5437 pubmed publisher
  39. Guo L, Chen G, Zhang W, Zhou L, Xiao T, Di X, et al. A high-risk luminal A dominant breast cancer subtype with increased mobility. Breast Cancer Res Treat. 2019;175:459-472 pubmed publisher
  40. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  41. Golay J, Valgardsdottir R, Musaraj G, Giupponi D, Spinelli O, Introna M. Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation. Blood. 2019;: pubmed publisher
  42. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  43. Buchrieser J, Oliva Martin M, Moore M, Long J, Cowley S, Perez Simon J, et al. RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation. Cell Death Dis. 2018;9:973 pubmed publisher
  44. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  45. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  46. Chennupati V, Veiga D, Maslowski K, Andina N, Tardivel A, Yu E, et al. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation. J Clin Invest. 2018;128:1597-1614 pubmed publisher
  47. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  48. Vitallé J, Zenarruzabeitia O, Terrén I, Plana M, Guardo A, Leal L, et al. Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. Front Immunol. 2017;8:836 pubmed publisher
  49. Blázquez Moreno A, Park S, Im W, Call M, Call M, Reyburn H. Transmembrane features governing Fc receptor CD16A assembly with CD16A signaling adaptor molecules. Proc Natl Acad Sci U S A. 2017;114:E5645-E5654 pubmed publisher
  50. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  51. van den Bosch T, Caliskan K, Kraaij M, Constantinescu A, Manintveld O, Leenen P, et al. CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection. Front Immunol. 2017;8:346 pubmed publisher
  52. Chimen M, Yates C, McGettrick H, Ward L, Harrison M, Apta B, et al. Monocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling through TNF and IL-6 at the Endothelial Cell Interface. J Immunol. 2017;198:2834-2843 pubmed publisher
  53. Esnault S, Johansson M, Kelly E, Koenderman L, Mosher D, Jarjour N. IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. Clin Exp Allergy. 2017;47:488-498 pubmed publisher
  54. Su J, Zhou H, Liu X, Nilsson J, Fredrikson G, Zhao M. oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+ /K+ channel flow. J Cell Mol Med. 2017;21:929-940 pubmed publisher
  55. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  56. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  57. Rathod K, Kapil V, Velmurugan S, Khambata R, Siddique U, Khan S, et al. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017;127:169-182 pubmed publisher
  58. Mildner A, Huang H, Radke J, Stenzel W, Priller J. P2Y12 receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases. Glia. 2017;65:375-387 pubmed publisher
  59. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  60. Geng S, Chen K, Yuan R, Peng L, Maitra U, Diao N, et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun. 2016;7:13436 pubmed publisher
  61. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
  62. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  63. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  64. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  65. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  66. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  67. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  68. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed publisher
  69. Wonner R, Wallner S, Orso E, Schmitz G. Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry B Clin Cytom. 2018;94:596-605 pubmed publisher
  70. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  71. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  72. Hohos N, Lee K, Ji L, Yu M, Kandasamy M, Phillips B, et al. DNA cytosine hydroxymethylation levels are distinct among non-overlapping classes of peripheral blood leukocytes. J Immunol Methods. 2016;436:1-15 pubmed publisher
  73. Liao R, Jiang N, Tang Z, Li D, Huang P, Luo S, et al. Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery. Oncotarget. 2016;7:30951-61 pubmed publisher
  74. Coughlin J, Masci A, Gronke R, Bergelson S, Co C. A simple enzyme-substrate localized conjugation method to generate immobilized, functional glutathione S-transferase fusion protein columns for affinity enrichment. Anal Biochem. 2016;505:51-8 pubmed publisher
  75. Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri V. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. Sci Rep. 2016;6:23942 pubmed publisher
  76. Parameswaran R, Ramakrishnan P, Moreton S, Xia Z, Hou Y, Lee D, et al. Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun. 2016;7:11154 pubmed publisher
  77. Keyvani Chahi A, Martin C, Jones N. Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP. J Biol Chem. 2016;291:12799-808 pubmed publisher
  78. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  79. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  80. Bartlett D, Fox O, McNulty C, Greenwood H, Murphy L, Sapey E, et al. Habitual physical activity is associated with the maintenance of neutrophil migratory dynamics in healthy older adults. Brain Behav Immun. 2016;56:12-20 pubmed publisher
  81. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  82. Mewhort H, Lipon B, Svystonyuk D, Teng G, Guzzardi D, Silva C, et al. Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1. Am J Physiol Heart Circ Physiol. 2016;310:H716-24 pubmed publisher
  83. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  84. Borinskaya S, Velle K, Campellone K, Talman A, Alvarez D, Agaisse H, et al. Integration of linear and dendritic actin nucleation in Nck-induced actin comets. Mol Biol Cell. 2016;27:247-59 pubmed publisher
  85. He Y, Wang C, Yu Y, Qian J, Song K, Sun Q, et al. Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection. PLoS ONE. 2015;10:e0143657 pubmed publisher
  86. Eskicioğlu F, Özdemir A, Özdemir R, Turan G, Akan Z, Hasdemir S. The association of HLA-G and immune markers in recurrent miscarriages. J Matern Fetal Neonatal Med. 2016;29:3056-60 pubmed publisher
  87. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  88. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  89. Sakthivel P, Grunewald J, Eklund A, Bruder D, Wahlström J. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution. Clin Exp Immunol. 2016;183:294-306 pubmed publisher
  90. WILLIAMS K, KILLEBREW D, Clary G, Seawell J, Meeker R. Differential regulation of macrophage phenotype by mature and pro-nerve growth factor. J Neuroimmunol. 2015;285:76-93 pubmed publisher
  91. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  92. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  93. O Brien E, Abdulahad W, Rutgers A, Huitema M, O Reilly V, Coughlan A, et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Sci Rep. 2015;5:11888 pubmed publisher
  94. Chalan P, Bijzet J, Huitema M, Kroesen B, Brouwer E, Boots A. Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. PLoS ONE. 2015;10:e0132436 pubmed publisher
  95. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  96. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  97. Weldon A, Moldovan I, Cabling M, Hernandez E, Hsu S, Gonzalez J, et al. Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. J Rheumatol. 2015;42:749-59 pubmed publisher
  98. Rönn R, Guibentif C, Moraghebi R, Chaves P, Saxena S, Garcia B, et al. Retinoic acid regulates hematopoietic development from human pluripotent stem cells. Stem Cell Reports. 2015;4:269-81 pubmed publisher
  99. Chauhan A, Chen C, Moore T, DiPaolo R. Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset. J Biol Chem. 2015;290:5127-40 pubmed publisher
  100. Hünniger K, Bieber K, Martin R, Lehnert T, Figge M, Löffler J, et al. A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a. J Immunol. 2015;194:1199-210 pubmed publisher
  101. Hartung E, Becker M, Bachem A, Reeg N, Jäkel A, Hutloff A, et al. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1. J Immunol. 2015;194:1069-79 pubmed publisher
  102. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  103. Presnell S, Al Attar A, Cichocki F, Miller J, Lutz C. Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs. Genes Immun. 2015;16:89-98 pubmed publisher
  104. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  105. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed publisher
  106. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed publisher
  107. Liu H, Yang B, Sun T, Lin L, Hu Y, Deng M, et al. Specific growth inhibition of ErbB2‑expressing human breast cancer cells by genetically modified NK‑92 cells. Oncol Rep. 2015;33:95-102 pubmed publisher
  108. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed publisher
  109. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  110. Holder G, McGary C, Johnson E, Zheng R, John V, Sugimoto C, et al. Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection. J Neuroimmune Pharmacol. 2014;9:716-26 pubmed publisher
  111. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  112. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  113. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  114. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  115. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  116. Reusch U, Burkhardt C, Fucek I, Le Gall F, Le Gall M, Hoffmann K, et al. A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells. MAbs. 2014;6:728-39 pubmed publisher
  117. Düvel A, Maaß J, Heppelmann M, Hussen J, Koy M, Piechotta M, et al. Peripheral blood leukocytes of cows with subclinical endometritis show an altered cellular composition and gene expression. Theriogenology. 2014;81:906-17 pubmed publisher
  118. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed publisher
  119. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  120. Kragstrup T, Jalilian B, Hvid M, Kjærgaard A, Østgård R, Schiøttz Christensen B, et al. Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis. Arthritis Res Ther. 2014;16:R42 pubmed publisher
  121. Cepeda M, Salas M, Folwarczny J, Leandro A, Hodara V, De La Garza M, et al. Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2013;93 Suppl:S51-9 pubmed publisher
  122. Babu R, Brown A. A consensus surface activation marker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages. Retrovirology. 2013;10:155 pubmed publisher
  123. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Bishop D, et al. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis. Transfusion. 2014;54:1305-16 pubmed publisher
  124. Chicoine L, Rodino Klapac L, Shao G, Xu R, Bremer W, Camboni M, et al. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin ?2 surrogates. Mol Ther. 2014;22:713-24 pubmed publisher
  125. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  126. Wiernik A, Foley B, Zhang B, Verneris M, Warlick E, Gleason M, et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19:3844-55 pubmed publisher
  127. Algra S, Groeneveld K, Schadenberg A, Haas F, Evens F, Meerding J, et al. Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgery. J Neuroinflammation. 2013;10:24 pubmed publisher
  128. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  129. Daigneault M, de Silva T, Bewley M, Preston J, Marriott H, Mitchell A, et al. Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection. PLoS Pathog. 2012;8:e1002814 pubmed publisher
  130. Kvistborg P, Shu C, Heemskerk B, Fankhauser M, Thrue C, Toebes M, et al. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology. 2012;1:409-418 pubmed
  131. Seu L, Burt T, Witte J, Martin J, Deeks S, McCune J. Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans. Genes Immun. 2012;13:258-67 pubmed publisher
  132. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  133. Qian B, Li J, Zhang H, Kitamura T, Zhang J, Campion L, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222-5 pubmed publisher
  134. Bratke K, Klein C, Kuepper M, Lommatzsch M, Virchow J. Differential development of plasmacytoid dendritic cells in Th1- and Th2-like cytokine milieus. Allergy. 2011;66:386-95 pubmed publisher
  135. Rout N, Else J, Yue S, Connole M, Exley M, Kaur A. Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys. J Med Primatol. 2010;39:224-34 pubmed publisher
  136. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed publisher
  137. Schrauf C, Kirchberger S, Majdic O, Seyerl M, Zlabinger G, Stuhlmeier K, et al. The ssRNA genome of human rhinovirus induces a type I IFN response but fails to induce maturation in human monocyte-derived dendritic cells. J Immunol. 2009;183:4440-8 pubmed publisher
  138. Tanaka M, Krutzik S, Sieling P, Lee D, Rea T, Modlin R. Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses. J Immunol. 2009;183:2349-55 pubmed publisher
  139. Hokey D, Yan J, Hirao L, Dai A, Boyer J, Jure Kunkel M, et al. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response. J Med Primatol. 2008;37 Suppl 2:62-8 pubmed publisher
  140. Giannelli S, Taddeo A, Presicce P, Villa M, Della Bella S. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B Clin Cytom. 2008;74:349-55 pubmed publisher
  141. Sathler Avelar R, Vitelli Avelar D, Massara R, de Lana M, Pinto Dias J, Teixeira Carvalho A, et al. Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect. 2008;10:103-13 pubmed publisher
  142. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  143. Summers K, Marleau A, Mahon J, McManus R, Hramiak I, Singh B. Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol. 2006;121:81-9 pubmed
  144. Hirano N, Butler M, Xia Z, Ansén S, von Bergwelt Baildon M, Neuberg D, et al. Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood. 2006;107:1528-36 pubmed
  145. Siliciano J, Siliciano R. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304:3-15 pubmed
  146. Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, Zlabinger G, et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol. 2005;175:1145-52 pubmed
  147. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  148. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  149. Pfistershammer K, Majdic O, Stockl J, Zlabinger G, Kirchberger S, Steinberger P, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173:6000-8 pubmed
  150. Eriksson M, Meadows S, Wira C, Sentman C. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol. 2004;76:667-75 pubmed
  151. Steinberger P, Majdic O, Derdak S, Pfistershammer K, Kirchberger S, Klauser C, et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol. 2004;172:2352-9 pubmed
  152. Suskind D, Muench M. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol. 2004;40:261-8 pubmed
  153. Rahimi K, Maerz H, Zotz R, Tarnok A. Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease. Cytometry B Clin Cytom. 2003;53:63-9 pubmed
  154. Selenko Gebauer N, Majdic O, Szekeres A, Höfler G, Guthann E, Korthauer U, et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol. 2003;170:3637-44 pubmed
  155. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  156. Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodeghiero F. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Haematologica. 2002;87:250-6 pubmed
  157. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  158. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  159. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  160. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  161. Ravetch J, Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med. 1989;170:481-97 pubmed
  162. Peltz G, Grundy H, Lebo R, Yssel H, Barsh G, Moore K. Human Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc Natl Acad Sci U S A. 1989;86:1013-7 pubmed